Media was removed and replaced with either fresh DMEM with 10% FCS alone or 10% FCS that had been previously mixed with pristane. 12 At three time points (0, 6, and 24 h after replacement of ...

Researchers from Ermium Therapeutics SAS have presented preclinical data for the novel chemokine CXCR4 receptor ligand ER-000145, being developed for the treatment of type 1 interferonopathies, such ...